Mary Crowley Cancer Research — Dallas, Texas

Mary Crowley Cancer Research is a clinical research site located in Dallas, Texas, United States 75230.

Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

Mary Crowley Cancer Research has participated in 114 clinical trials with 47 currently active.

Therapeutic areas: Non-Small-Cell Lung Cancer, Lung Cancer, Lung Cancer Metastatic.

Sponsors: BioAtla, Inc., Sutro Biopharma, Inc., Numab Therapeutics AG.

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mary Crowley Cancer Research?

Mary Crowley Cancer Research has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mary Crowley Cancer Research conducted?

Mary Crowley Cancer Research has 114 clinical trials on record, with 47 currently active. Their work covers Non-Small-Cell Lung Cancer, Lung Cancer, Lung Cancer Metastatic.

Is Mary Crowley Cancer Research accredited by Crixeo Health?

Mary Crowley Cancer Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mary Crowley Cancer Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.